Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
9/30/2025 | $ -241.36M | $ -2.87 | 1 | 84.16M |
6/30/2025 | $ -225.79M | $ -2.69 | 1 | 83.88M |
3/31/2025 | $ -201.59M | $ -2.41 | 1 | 83.56M |
12/31/2024 | $ -181.86M | $ -2.71 | 1 | 67.12M |
9/30/2024 | $ -106.9M | $ -1.47 | 1 | 72.78M |
6/30/2024 | $ -105.97M | $ -1.7 | 1 | 62.38M |
3/31/2024 | $ -83.87M | $ -1.53 | 1 | 54.9M |
12/31/2023 | $ -89.77M | $ -1.65 | 1 | 54.34M |
9/30/2023 | $ -154.39M | $ -2.84 | 1 | 54.39M |
6/30/2023 | $ -160.52M | $ -2.96 | 1 | 54.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for NURIX THERAPEUTICS INC is calculated as follows: FCF [ $ -4.63M ] / (Shares WA [ 15.67M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -0.3 ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.85 |
average | $ 0.8 |
median | $ 0.29 |
std | $ 2.82 |